Hydroxyurea to Prevent Organ Damage in Children With Sickle Cell Anemia

Completed

Plain-English translation of NCT00006400 on ClinicalTrials.gov ↗ · Source last updated August 2020 · How we translate trials

Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.

Trial locations(14 sites)

United States

University of Alabama at Birmingham, Birmingham, Alabama

Children's National Medical Center, Washington D.C., District of Columbia

Howard University, Washington D.C., District of Columbia

University of Miami, Miami, Florida

Emory University School of Medicine, Atlanta, Georgia